Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

著录项

• 来源
  《Annals of oncology: official journal of the European Society for Medical Oncology》 |2018年第8期|共5页
• 作者

  Verstovsek S.; Subbiah V.; Masarova L.; Yin C. Cameron; Tang G.; Manshouri T.; Asatiani E.; Daver N. G.;

  展开▼
• 作者单位

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Dept Invest Canc Therapeut Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Dept Hematopathol Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Dept Hematopathol Houston TX 77030 USA;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  Incyte Corp Wilmington DE USA;

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词